WallStreetZenWallStreetZen

How to Buy Seres Therapeutics Stock

Seres Therapeutics Inc

Seres Therapeutics, Inc. , a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease.

Seres Therapeutics stock last closed at $0.74, up 1.78% from the previous day, and has decreased 87.94% in one year. It has underperformed other stocks in the Biotechnology industry by 0.64 percentage points. Seres Therapeutics stock is currently +37.59% from its 52-week low of $0.54, and -88.83% from its 52-week high of $6.65.

There are currently 151.01M MCRB shares outstanding. The market capitalization of MCRB is $112.20M. In the last 24 hours, 3.43M MCRB shares were traded.

How to Buy Seres Therapeutics Stock

Wondering how to invest in Seres Therapeutics stock? Here's how.
  1. Choose where to buy Seres Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Seres Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Fund your investment account: Pick your payment method and add your details.
  4. Research Seres Therapeutics stock: The Seres Therapeutics ticker symbol is MCRB. Is Seres Therapeutics stock a good investment? Should you buy shares of MCRB? How do MCRB's underlying business fundamentals look? Do top analysts think Seres Therapeutics is a good buy? Why has MCRB's stock price moved recently? (Hint: Our stock research tools can help you figure out if MCRB is a good stock to buy).
  5. Execute your MCRB trade: Decide if you will purchase MCRB shares at the current market price or use a limit order to purchase MCRB shares at a given price.
  6. Get the latest scoop on your MCRB position: Create a watchlist to important updates regarding your new investment in Seres Therapeutics stock.

Step 1: Choose where to buy Seres Therapeutics stock

You need a brokerage account in order to access the NASDAQ market and buy MCRB stock.

A brokerage account enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've selected the best brokerage, you need to fill out some personal information so you can buy MCRB stock today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to open your new brokerage account.
  1. Send your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have filled out your info on the best stock app, you need to deposit funds:

Watch the video below to see the process of transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Seres Therapeutics stock

Once you have identified the best place to buy Seres Therapeutics stock, it's absolutely critical to evaluate their stock prior to buying, so you truly understand the risk and opportunity.

Seres Therapeutics Numbers

MCRB Price
$0.74
1w %
27.23%
1y %
-87.94%
5y %
-89.28%
P/E
-0.83x
P/B
-2.5x
P/S
0.75x
PEG
N/A
Revenue
$126.33M
Earnings
-$113.72M
Fore. Rev. Growth
5.95%
Fore. Earn. Growth
N/A
Market Cap
$112.20M
Next Earnings
May 7, 2024
Next Dividend
N/A

MCRB Fundamentals

WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis quickly.

You can see all of the due diligence checks on MCRB's stock page.

What is the fair value of MCRB stock?

Investors use many financial metrics, analyses, models, and charts to gauge MCRB's true value.

You can do more valuation analysis on MCRB's stock here.

A look at MCRB Cashflows and Balance Sheet

Passed Health Checks:

  • There are more short-term assets than short-term liabilities on the MCRB balance sheet.
  • MCRB has cash burn of 125329000. It has enough cash and short-term investments to cover this for at least one year.

Failed Health Checks:

  • MCRB profit margin has gone up by 34.2 percentage points in the past year, but the company is still unprofitable.
  • There are more long-term liabilities than short-term assets on the MCRB balance sheet.
  • MCRB debt to equity ratio of -8.99 is negative.
  • Total MCRB debt is still negative.
  • MCRB has $136.15M in cash and short term investments. This is not enough to cover its annual cash burn of $125.33M.

Do analysts think it's a good time to buy MCRB stock

Out of 3 sell side analysts who give ratings on MCRB, the consensus analyst rating on MCRB is a Hold

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Seres Therapeutics stock forecast page.

MCRB Momentum

SMA10
0.65
SMA20
0.69
SMA50
0.85
SMA100
1.02
SMA200
1.87
MACD
-0.04
MACD Signal
-0.06
MACD Histogram
0.02
RSI
50.95
Stochastic %K
75.38
Stochastic %D
60.19
StochRSI %K
94.34
StochRSI %D
81.91

MCRB Performance Metrics

Last year, MCRB revenue was $126.33M. In the past five year, MCRB's revenue has increased by 34.91% per year. This was faster than the Biotechnology industry average of 28.62%.

You can analyze MCRB's earnings and revenue performance here.

What are MCRB executives and large shareholders up to?

In the past year, executives and large shareholders at MCRB have sold more shares than they have bought.

David Arkowitz, Chief Financial Officer of MCRB, was the latest MCRB insider to sell. They sold $4,254.12 worth of MCRB stock on Feb 16, 2024.

Learn more about who owns MCRB shares here.

Can I rely on MCRB as an income stream?

No, Seres Therapeutics doesn't provide an income stream by paying out dividends.

MCRB Social Trading Data

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your MCRB trade

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are mostly sufficient.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a specific price, use a limit order.

Hit the Open Trade button and eToro will execute the order.

If you want more info about buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest scoop on your MCRB position

Now that you own some shares in MCRB, you'll want to stay up-to-date on your new investment.

Start a watchlist to see the latest developments about your MCRB stock.

MCRB Feed

How to Buy Stock in Seres Therapeutics

To reiterate, here are the 6 steps you need to take to buy Seres Therapeutics stock right now:

  1. Choose where to buy Seres Therapeutics stock
  2. Open a brokerage account
  3. Fund your investment account
  4. Research Seres Therapeutics stock
  5. Execute your MCRB trade
  6. Get the latest scoop on your MCRB position

If you are looking for a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to monitor your new investment in Seres Therapeutics, hit the button below to create your watchlist.

NASDAQ: MCRB
$0.74+0.01 (+1.78%)
Updated Apr 25, 2024
Open eToro Account
NASDAQ: MCRB
$0.74+0.01 (+1.78%)
Updated Apr 25, 2024
Open eToro Account

FAQ

How much does it cost to buy one Seres Therapeutics share?

As of Apr 25, 2024, it costs $0.74 to buy one share of Seres Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.37, you can buy 0.5 shares of MCRB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Seres Therapeutics stock?

According to 3 Wall Street analysts who monitor Seres Therapeutics, their consensus recommendation is to hold Seres Therapeutics stock.

What is the best way to buy Seres Therapeutics stock?

One way to place an order for Seres Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.